Keenova Therapeutics plc financial data

Location
Dublin 15
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 10 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 345% % 2%
Quick Ratio 133% % -21%
Debt-to-equity 128% % -46%
Return On Equity 15% %
Return On Assets 6.5% %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 39,526,162 shares 101%
Common Stock, Shares, Outstanding 19,736,759 shares 0.2%
Weighted Average Number of Shares Outstanding, Basic 32,300,000 shares 64%
Weighted Average Number of Shares Outstanding, Diluted 32,300,000 shares 64%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense $118,800,000 USD 17%
Operating Income (Loss) $177,000,000 USD -783%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $391,300,000 USD -1621%
Income Tax Expense (Benefit) $96,200,000 USD 676%
Net Income (Loss) Attributable to Parent $296,400,000 USD -1011%
Earnings Per Share, Basic 20 USD/shares -577%
Earnings Per Share, Diluted -9.01 USD/shares -577%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $1,047,900,000 USD 155%
Accounts Receivable, after Allowance for Credit Loss, Current $757,900,000 USD 98%
Inventory, Net $1,322,300,000 USD 86%
Other Assets, Current $186,300,000 USD 34%
Assets, Current $3,458,400,000 USD 101%
Deferred Income Tax Assets, Net $843,600,000 USD 8.6%
Property, Plant and Equipment, Net $831,600,000 USD 130%
Operating Lease, Right-of-Use Asset $56,300,000 USD 11%
Intangible Assets, Net (Excluding Goodwill) $2,560,400,000 USD 490%
Goodwill $7,300,000 USD
Other Assets, Noncurrent $766,400,000 USD 238%
Assets $8,467,700,000 USD 133%
Accounts Payable, Current $165,400,000 USD 96%
Employee-related Liabilities, Current $146,000,000 USD 62%
Liabilities, Current $1,071,100,000 USD 93%
Long-term Debt and Lease Obligation $3,690,600,000 USD 113%
Accrued Income Taxes, Noncurrent $34,900,000 USD 36%
Deferred Income Tax Liabilities, Net $100,000 USD
Operating Lease, Liability, Noncurrent $45,000,000 USD 0.45%
Other Liabilities, Noncurrent $351,100,000 USD 250%
Liabilities $5,316,400,000 USD 104%
Accumulated Other Comprehensive Income (Loss), Net of Tax $13,300,000 USD 375%
Retained Earnings (Accumulated Deficit) $121,400,000 USD
Stockholders' Equity Attributable to Parent $3,151,300,000 USD 206%
Liabilities and Equity $8,467,700,000 USD 133%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $66,300,000 USD 320%
Net Cash Provided by (Used in) Financing Activities $3,100,000 USD -41%
Net Cash Provided by (Used in) Investing Activities $24,000,000 USD 0.83%
Common Stock, Shares Authorized 500,000,000 shares 0%
Common Stock, Shares, Issued 19,762,306 shares 0.34%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $40,000,000 USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $1,203,000,000 USD 153%
Deferred Tax Assets, Valuation Allowance $73,000,000 USD
Deferred Tax Assets, Gross $4,499,600,000 USD -18%
Operating Lease, Liability $55,800,000 USD 0.9%
Depreciation $41,700,000 USD 13%
Payments to Acquire Property, Plant, and Equipment $24,300,000 USD -1.2%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $306,900,000 USD -1460%
Lessee, Operating Lease, Liability, to be Paid $75,700,000 USD 1.3%
Property, Plant and Equipment, Gross $908,100,000 USD 128%
Operating Lease, Liability, Current $10,800,000 USD 2.9%
Lessee, Operating Lease, Liability, to be Paid, Year Two $12,400,000 USD -6.1%
Lessee, Operating Lease, Liability, to be Paid, Year One $16,800,000 USD 17%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure -25%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $19,900,000 USD 2.6%
Lessee, Operating Lease, Liability, to be Paid, Year Three $10,200,000 USD 15%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 500,000,000 shares 0%
Unrecognized Tax Benefits $34,200,000 USD 15%
Lessee, Operating Lease, Liability, to be Paid, Year Four $9,100,000 USD 32%
Additional Paid in Capital $3,016,200,000 USD 152%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets $88,400,000 USD 7.4%
Depreciation, Depletion and Amortization $22,500,000 USD -36%
Interest Expense $175,200,000 USD -37%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%